Medication for Opioid Use Disorder and Treatment Retention Among Pregnant Individuals
In this cross-sectional study of treatment episodes from ambulatory, nonintensive facilities, MOUD inclusion among pregnant individuals was associated with significant improvements in treatment retention. However, retention remained low during the HPSO era. These findings underscore the importance of MOUD in improving OUD-related outcomes in this high-risk population.
Authors
- Alene Kennedy‐Hendricks (ORCID: https://orcid.org/0000-0001-5747-0538)
- Valerie S. Ganetsky (ORCID: https://orcid.org/0000-0003-2852-7616)
- Noa Krawczyk (ORCID: https://orcid.org/0000-0002-7396-3938)
Institutions
- Johns Hopkins University (US)
- New York University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.6069
- Citations
- 3
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 10.48
Funders
- Centers for Disease Control and Prevention
- National Institute of Mental Health